Update shared on 06 Dec 2025
Analysts have nudged their price targets on Allianz higher, with recent moves such as Citi lifting its target to EUR 388 from EUR 349.90 and JPMorgan to EUR 360 from EUR 350. They cite a slightly stronger revenue growth outlook that more than offsets marginally softer profit margin assumptions and leaves longer term valuation multiples broadly unchanged.
Analyst Commentary
Analyst opinion on Allianz has turned incrementally more constructive, with recent target price increases reflecting confidence in the insurer's ability to deliver steady growth and capital returns without requiring a material re-rating of the shares.
Bullish analysts view the recent target hikes as validation that Allianz's fundamentals are improving at the margin, even as valuation multiples remain broadly stable.
Bullish Takeaways
- Bullish analysts see the higher price targets as supported by a firmer top line outlook, particularly in core insurance and asset management operations, which underpins mid single digit earnings growth.
- Rising targets are interpreted as a sign that execution on cost discipline and underwriting quality is tracking ahead of prior expectations, supporting a resilient margin profile despite mixed market conditions.
- The combination of steady earnings, a strong capital position and reliable dividend growth is viewed as attractive in a sector where visibility on cash generation and payouts is increasingly prized.
- From a valuation standpoint, bullish analysts argue that modest upgrades, without stretching multiples, leave scope for further upside if Allianz continues to beat operational targets.
Bearish Takeaways
- Bearish analysts maintain more cautious stances on the shares, suggesting that, while fundamentals have improved, much of the good news is already reflected in current valuations.
- There is concern that softer margin assumptions and macro uncertainty could cap earnings upgrades, limiting the extent of future price target increases.
- Some remain wary that, in a competitive European insurance landscape, Allianz may find it difficult to materially accelerate growth without taking on higher risk or compressing returns.
- Neutral ratings, even alongside higher targets, imply that a portion of the market still views the risk reward as balanced rather than compelling at current levels.
What's in the News
- Raised 2025 guidance, with Allianz now expecting operating profit of at least EUR 17 billion, likely in a range of EUR 17 billion to EUR 17.5 billion, signalling confidence in earnings momentum (company guidance).
Valuation Changes
- Fair Value: Unchanged at approximately €371.92 per share, indicating no shift in the intrinsic value estimate.
- Discount Rate: Stable at about 4.93 percent, suggesting no change in perceived risk or cost of capital assumptions.
- Revenue Growth: Risen slightly from around 23.78 percent to 24.00 percent, reflecting a marginally stronger top line outlook.
- Net Profit Margin: Eased slightly from roughly 6.41 percent to 6.38 percent, pointing to a modestly softer profitability assumption.
- Future P/E: Edged down marginally, remaining at about 12.21x and leaving the valuation multiple effectively unchanged.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
